Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$31.15 - $33.39 $23,549 - $25,242
756 Added 1.39%
55,229 $1.83 Million
Q3 2022

Nov 18, 2022

SELL
$30.9 - $33.55 $30,652 - $33,281
-992 Reduced 1.79%
54,473 $1.72 Million
Q2 2022

Aug 15, 2022

BUY
$23.75 - $31.69 $55,693 - $74,313
2,345 Added 4.41%
55,465 $1.69 Million
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $93,998 - $126,806
-4,707 Reduced 8.14%
53,120 $1.38 Million
Q4 2021

Feb 15, 2022

BUY
$17.46 - $21.61 $12,222 - $15,127
700 Added 1.23%
57,827 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$17.35 - $22.5 $29,113 - $37,755
-1,678 Reduced 2.85%
57,127 $1.1 Million
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $90,770 - $142,732
-5,040 Reduced 7.89%
58,805 $1.3 Million
Q1 2021

May 18, 2021

SELL
$19.76 - $29.89 $3,853 - $5,828
-195 Reduced 0.3%
63,845 $1.68 Million
Q3 2020

Nov 17, 2020

BUY
$13.54 - $26.41 $5,808 - $11,329
429 Added 0.67%
64,040 $1.09 Million
Q1 2020

May 13, 2020

SELL
$5.57 - $11.5 $11,234 - $23,195
-2,017 Reduced 3.07%
63,611 $534,000
Q3 2019

Nov 15, 2019

BUY
$9.17 - $12.01 $7,189 - $9,415
784 Added 1.21%
65,628 $623,000
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $13,306 - $21,524
1,223 Added 1.92%
64,844 $770,000
Q1 2019

May 09, 2019

SELL
$15.51 - $17.61 $21,931 - $24,900
-1,414 Reduced 2.17%
63,621 $1.12 Million
Q4 2018

Feb 13, 2019

BUY
$14.52 - $19.72 $21,010 - $28,534
1,447 Added 2.28%
65,035 $1.13 Million
Q3 2018

Nov 14, 2018

SELL
$14.85 - $16.35 $44 - $49
-3 Reduced -0.0%
63,588 $947,000
Q2 2018

Aug 14, 2018

BUY
$13.8 - $16.8 $4,940 - $6,014
358 Added 0.57%
63,591 $1.01 Million
Q1 2018

May 15, 2018

SELL
$13.8 - $16.2 $33,506 - $39,333
-2,428 Reduced 3.7%
63,233 $898,000
Q4 2017

Feb 14, 2018

SELL
$13.55 - $15.8 $12,818 - $14,946
-946 Reduced 1.42%
65,661 $919,000
Q3 2017

Nov 13, 2017

BUY
$13.45 - $14.35 $895,864 - $955,810
66,607
66,607 $952,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.